These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5679194)

  • 1. [The cost of drugs].
    Hamel G
    Laval Med; 1968 Jun; 39(6):488-94. PubMed ID: 5679194
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmaceutical aspect of the cost of drugs].
    Mockle JA
    Laval Med; 1968 Jun; 39(6):477-87. PubMed ID: 5679193
    [No Abstract]   [Full Text] [Related]  

  • 3. The Canadian Medical Association brief to the Parliamentary Committee on Food and Drugs.
    Can Med Assoc J; 1966 Aug; 95(7):324-30. PubMed ID: 5969351
    [No Abstract]   [Full Text] [Related]  

  • 4. Achieving a quality drug supply.
    Nelson G
    J Am Pharm Assoc; 1974 Oct; 14(10):548-9, 564. PubMed ID: 4420394
    [No Abstract]   [Full Text] [Related]  

  • 5. Institute of Medicine's new drug safety report: implications for Canada.
    Cassels A
    CMAJ; 2006 Dec; 175(12):1515-6. PubMed ID: 17146086
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmaceutical specialities: definitions and rules for manufacturing and marketing in Italy].
    Germani C; Montanari L; Petraroja A
    Boll Chim Farm; 1979 Mar; 118(3):135-43. PubMed ID: 475905
    [No Abstract]   [Full Text] [Related]  

  • 7. [Harmful effects of drugs. Liability of the manufacturers against insurance claims for damages].
    Dahl B
    Ugeskr Laeger; 1984 Sep; 146(36):2726-8. PubMed ID: 6515894
    [No Abstract]   [Full Text] [Related]  

  • 8. [Perspectives in the development of drug consumption].
    Fikr V; Federmann J
    Cesk Zdrav; 1970 Jan; 18(1):14-20. PubMed ID: 5412585
    [No Abstract]   [Full Text] [Related]  

  • 9. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products.
    Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700
    [No Abstract]   [Full Text] [Related]  

  • 10. Expired drugs are not dead drugs.
    Torigian PC
    Am J Hosp Pharm; 1993 Mar; 50(3):448. PubMed ID: 8442459
    [No Abstract]   [Full Text] [Related]  

  • 11. A proposed European pharmacopeia monograph for continuous cell lines derived drugs.
    Dorpema JW
    Dev Biol Stand; 1989; 70():113-24. PubMed ID: 2759345
    [No Abstract]   [Full Text] [Related]  

  • 12. Rx: Canadian drugs.
    Rawson NS
    N Engl J Med; 2004 Mar; 350(11):1155. PubMed ID: 15017685
    [No Abstract]   [Full Text] [Related]  

  • 13. Sometimes a "non-returnable" basis for drugs is justified.
    Davis NM
    Hosp Pharm; 1976 Jul; 11(7):254. PubMed ID: 1029731
    [No Abstract]   [Full Text] [Related]  

  • 14. [Importance of patents for the qualitative level in the evaluation of drugs].
    Rovati AL
    Boll Chim Farm; 1971 Oct; 110(10):569-72. PubMed ID: 5143354
    [No Abstract]   [Full Text] [Related]  

  • 15. Anticipated revisions to the current good manufacturing practice regulations.
    Mitchell CM
    Bull Parenter Drug Assoc; 1974; 28(3):146-51. PubMed ID: 4845938
    [No Abstract]   [Full Text] [Related]  

  • 16. Extra-label drug use--pharmaceutical industry view.
    Welser JR
    J Am Vet Med Assoc; 1993 May; 202(10):1635-42;discussion 1654-8. PubMed ID: 8514571
    [No Abstract]   [Full Text] [Related]  

  • 17. New countermeasures considered as drug counterfeiting grows.
    Schubert C
    Nat Med; 2008 Jul; 14(7):700. PubMed ID: 18607355
    [No Abstract]   [Full Text] [Related]  

  • 18. Spurious and counterfeit drugs: a growing industry in the developing world.
    Gautam CS; Utreja A; Singal GL
    Postgrad Med J; 2009 May; 85(1003):251-6. PubMed ID: 19520877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The drug industry's viewpoint on the cost of drugs].
    Doré R
    Laval Med; 1968 Jun; 39(6):495-505. PubMed ID: 5679195
    [No Abstract]   [Full Text] [Related]  

  • 20. Counterfeit drugs: defining the problem and finding solutions.
    Wertheimer AI; Santella TM
    Expert Opin Drug Saf; 2005 Jul; 4(4):619-22. PubMed ID: 16011440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.